Avenue Therapeutics, Inc. Stock Forecast

High volatility in Avenue Therapeutics, Inc. stock price on Friday which ended trading at $6.20
(Updated on Apr 26, 2024)

ATXI Signals & Forecast

The Avenue Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.99 and $0.320. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, April 24, 2024, and so far it has risen 6,474.76%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Avenue Therapeutics, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $3.05 between high and low, or 52.77%. For the last week the stock has had daily average volatility of 27.34%.

The Avenue Therapeutics, Inc. stock is extremely overbought on RSI14 (99). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $6.04 (-2.52%) (This stock has high daily movements and this gives high risk. The RSI14 is 99 and this increases the risk substantially. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (ATXI) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Avenue Therapeutics, Inc. to open at $6.94, and during the day (based on 14 day Average True Range), to move between $5.56 and $6.84, which gives a possible trading interval of +/-$0.638 (+/-10.29%) up or down from last closing price. If Avenue Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 20.57% move between the lowest and the highest trading price during the day.

Is Avenue Therapeutics, Inc. stock A Buy?

Avenue Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Avenue Therapeutics, Inc. of Monday, April 29, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.